Cancer fears cast doubts on future of gene therapy.
Check
Erika
E
D048868:Adaptor Proteins, Signal Transducing; D026683:Advisory Committees / Q000331:legislation & jurisprudence; D002648:Child; D002986:Clinical Trials as Topic / Q000009:adverse effects / Q000331:legislation & jurisprudence; D004268:DNA-Binding Proteins / Q000235:genetics; D005602:France; D015316:Genetic Therapy / Q000009:adverse effects* / Q000639:trends*; D006801:Humans; D060588:LIM Domain Proteins; D007938:Leukemia / Q000209:etiology* / Q000235:genetics*; D008667:Metalloproteins / Q000235:genetics; D016254:Mutagenesis, Insertional; D009316:National Institutes of Health (U.S.); D017410:Practice Guidelines as Topic; D011518:Proto-Oncogene Proteins; D016511:Severe Combined Immunodeficiency / Q000235:genetics* / Q000628:therapy*; D014481:United States; D014486:United States Food and Drug Administration
D048868:Adaptor Proteins, Signal Transducing; D004268:DNA-Binding Proteins; D060588:LIM Domain Proteins; C085117:LMO2 protein, human; D008667:Metalloproteins; D011518:Proto-Oncogene Proteins